Comparison 5. Nevirapine once daily versus nevirapine and efavirenz.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Treatment failure on or before week 48	1	429	Risk Ratio (M‐H, Random, 95% CI)	0.82 [0.67, 1.00]
2 Undetectable plasma HIV RNA < 50 copies/ml at 48 weeks	1	429	Risk Ratio (M‐H, Random, 95% CI)	1.12 [0.98, 1.28]
3 Death	1	429	Risk Ratio (M‐H, Random, 95% CI)	3.33 [0.70, 15.82]